
Vogliwel 0.2mg Tablet
Marketer
Life Pharma
Salt Composition
Voglibose (0.2mg)
Overview Vogliwel 0.2mg Tablet
Diabetol 0.2mg tablets manage type 2 diabetes by regulating post-prandial hyperglycemia. Prescribed when diet and other therapies prove insufficient, Diabetol 0.2mg should be ingested immediately before meals. Dosage frequency is determined individually by your physician to optimize blood glucose control. Abrupt cessation is strongly discouraged; discontinuation must be discussed with your doctor to prevent potentially severe complications such as renal impairment or vision loss. This medication forms part of a comprehensive diabetes management plan, incorporating a healthy diet, exercise, and weight management as directed by your doctor. Regular blood glucose monitoring is essential. Common adverse effects include abdominal discomfort, decreased appetite, bowel irregularity (constipation or diarrhea), and flatulence. Report any persistent or bothersome side effects to your healthcare provider. While Diabetol 0.2mg itself doesn't cause hypoglycemia, concurrent use with other anti-diabetic agents (particularly insulin or sulfonylureas) may increase this risk. Treat hypoglycemic episodes with plain glucose; sucrose is ineffective in this context. Inform your doctor of any liver or kidney conditions before commencing treatment. This medicine is contraindicated in individuals with bowel inflammation (e.g., Crohn's disease or ulcerative colitis). Pregnant or lactating individuals should seek medical advice prior to use. Ensure your physician is aware of all other medications you are currently using. Limit alcohol consumption while taking Diabetol 0.2mg to mitigate the potential for hypoglycemia.
Uses of Vogliwel 0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Vogliwel 0.2mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Vogliwel 0.2mg Tablet on an empty stomach.
Common Side effects of Vogliwel 0.2mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Vogliwel 0.2mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 0.2mg Vogliwel tablet whole; do not chew, crush, or divide it. Administer this medicine on an empty stomach.
How Vogliwel 0.2mg Tablet works:
Vogliwel 0.2mg tablets function as an anti-diabetic medication by suppressing the activity of intestinal enzymes that digest complex carbohydrates. This action reduces postprandial hyperglycemia by hindering the rapid breakdown of sugars into glucose.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Vogliwel 0.2mg tablets is inadvisable.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Vogliwel 0.2mg tablets is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; however, clinical data in humans are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers may likely use Vogliwel 0.2mg tablets without significant risk to their infants. Available human data indicates minimal danger to the baby from this medication.
DrivingSAFE
Driving ability is typically unaffected by Vogliwel 0.2mg Tablets.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Vogliwel 0.2mg tablets. Dosage modification of Vogliwel 0.2mg tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Vogliwel 0.2mg tablets. Dosage modification of Vogliwel 0.2mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Vogliwel 0.2mg Tablet :
Omit any missed dose of Vogliwel 0.2mg Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vogliwel 0.2mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Alpha-glucosidase inhibitors |
